You are on page 1of 69

List of recommendations arranged according to system and diseases

(According to alphabetical order)


Central Nervous system
Community acquired Meningitis (CAM)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumonia Inj. Meropenem (2 gm) Tab. Teicoplanin (400 mg) stat and (200 mg)

Neisseria meningitides 8 hourly for 14 days plus/ or 12 hourly for 14 days plus/ or

Haemophilus influenza

Staphylococcus aureus Inj. Linezolid (600 mg) Inj. Acyclovir (5000 mg)

Herpes simplex 12 hourly 6 hourly for 14 days

Inj. Acyclovir (500 mg)

6 hourly for 14 days if viral infection

Name: S.I Avoid Imipenem


Pyogenic Meningitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumonia Inj. Vancomycin (30-45 mg/kg/day) Inj. Penicillin G

Neisseria meningitides 4-12 hourly interval + Inj. Meropenem

Listeria monocytogenes Inj. Gentamicin

Streptococcus agalactiae Inj. Ceftriaxone (2 gm) Inj. Amikacin

Haemophilus influenza 12 hourly 7-14 days

Escherichia coli

Name: Most of the patient came from different ICU with multiple drugs including two or more antibiotics with cultural and sensitivity report, so antibiotics choice mostly depends on c/s report
Dentistry
Acute variceal haemorrhage
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Somatostatin (250 μgm or 500 μgm) A bolus of is given


followed by an infusion of 6 mg/24 hour for 120 hrs

Portal Hypertension due to Cirrhosis of liver or non-cirrhotic portal Inj. Terlipressin (2 mg) 6 hourly for 48 hour. It may be continued for a further 3 days at 1
hypertension mg every 4 – 6 hourly

Inj. Octreotide (5 µgm) A bolus followed by (50 µgm/hour)

for up to 5 days

Cleft lip-palate, facial cleft, facial deformity correction surgery


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (1 gm) Inj. Meropenem (1 gm)

12 hourly 8 hourly I/V for 7 days, followed by Cap. Cephalosporins

Tab. Metronidazole (500 mg) Tab. Metronidazole

8 hourly for 5-7 days followed by or Cap. Cephalosporins

Tab. Metronidazole

Dental abscess
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Obligate anaerobes: Cap. Flucloxacillin Cap. Cepholosporins

Prevotella intermedia Tab. Metronidazole Cap. Cefixime


Prevotella nigresub Cap. Cefuroxime

Fusobacterium periodontices Tab. metronidazole

Phyromonas endodontics

Porphyromonas gingivalis

Name: For rapidly spreading infections injectable from may be advised


Denture sore mouth
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Candida albicans Antifungal agents eg, Nystatin powder or cream Antifungal agents eg, Nystatin powder or cream

Denture stomatitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Candida albicans 1 antifungal agents (eg, Nystatin powder or cream)

Extraction of tooth surgical/ non surgical


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Amoxicillin (500 mg)

8 hourly for 7 days or

Cap. Cefixime (200 mg)

2 of the other 3rd line antibiotic*

12 hourly for 7 days+

Tab. Metronidazole (400 mg)

8 hourly for 5 days.

Fungal infections in maxillofacial region like Candidiasis, mucormicosis etc


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Nystatin oral suspension (5-10 ml) of suspension Nystatin oral suspension (5-10 ml) of suspension

Fungus
for at least 14 days for at least 14 days.

Cap. Fluconazole (100 mg) Cap. Itraconazole (400 mg)

Fungus

daily for 7 – 14 days. 24 hourly for 7-14 days

Cap. Itraconazole (400 mg)

24 hourly for 7-14 days

Inj. Amikacin

Gingivitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Campylobacter rectus Tab. Penicillin V (250-500 mg)

Actinomyces species post operative 6 hourly for 5-7 days

Prevotella inginosus

Streptococcus Tab. Metronidazole (200-400 mg)

Cap. Doxycycline Initial : (200 mg/day) divided twice daily post operative first day then.
8 hourly for 3-5 days Maintenance : (100-200 mg/day) divided 12hrly

Cap. Doxycycline Initial : (200 mg/day)

divided twice daily post operative first day then. Maintenance :


(100-200 mg/day) divided 12 hourly

Name: Avoidance of Doxycycline, Metronidazole in growing patients and pregnant women.

Avoidance of antimicrobial drugs in patients having the history of that specific drug allergy.

Hepatorenal syndrome
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Inj. Human albumin (1 g/kg/day) bolus on presentation
Inj. Terlipressin (0.5-2.0 mg)
(maximum Dose, 100 gm daily)

Inj. Nor adrenaline (0.5- 3.0 mg/hour) continuous I/V infusion


every 4 – 6 hourly
[Sherlock]

Cirrhosis of liver with ascites with renal impairment

Inj. Octreotide (100-200 μgm)

subcutaneously 8 hourly

Inj. Midodrine (7.5-12.5 mg)

8 hourly

In case of maxillofacial fracture management like open reduction and fixation


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

3rd generation Ceftriaxone (1 mg )I/V Inj. Meropenem (1 gm)

12 hourly 8 hourly I/V for 7 days, following by Cap. Cephalosporins

Metronidazole (500 mg) I/V Tab. Metronidazole

8 hourly for 5-7 days followed by oral Cephalosporins

Tab. Metronidazole

In case of oral and maxillofacial lesion with or without reconstruction, like mendibulectomy, maxillectomy, neck dissection, etc
Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Inj. Ceftriaxone (1 mg) 12 hourly Inj. Meropenem (1 gm) 8 hourly for 7 days, following by Cap. Cephalosporins

Tab. Metronidazole (500 mg) Tab. Metronidazole

8 hourly for 5-7 days followed by Cap. Cephalosporins

Tab. Metronidazole

Jaw osteomyelitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Clindamycin (600 mg) Flucloxacillin (500 mg)

in divided dose for 6 days to 8 weeks ± 6 hourly for 6-8 weeks +

Mixed anaerobic infection. Commonly by staphylococci and enteric


microorganism

Tab. Metronidazole (500 mg) Tab. Secnidazole (2 gm)

8 hourly for 7 days single dose

Minor oral surgery like biopsy, excision of mucocele etc


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Amoxicillin (500 mg) Cap. Amoxicillin (500 mg) + Clavulanic acid (125 mg)

8 hourly for 7 days or 8 hourly or

Cap. Cefixime (200 mg) Cap. Cefuroxime (500 mg) + Clavulanic acid (125 mg)
12 hourly for 7 days + 12 hourly for 7 days +

Tab. Metronidazole (400 mg) Tab. Metronidazole (400 mg)

8 hourly for 5 days 8 hourly for 5-7 days

Oral Candidiasis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus

Antifungal agents eg, Nystatin powder or cream Clotrimazole or Nystatin lozenges


Peptostreptococcus

Bacteroides

Orofacial space infections


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Amoxicillin or Cap. Cephalosporins (Cephradine, Cefixime, Cap. Amoxicillin or Cap. Cephalosporins with Clavulanic acid + Tab. Secnidazole (2 gm)
Cefuroxime) (500 mg-1gm) in different dose single dose.

for 7 -14 days+ Cefuroxime (500 mg to 1 gm)


Polymicrobials of both anaerobic and aerobic

in different dose for 7-14 days

Tab. Metronidazole (500 mg)

8 hourly 7 days.

Peri implantitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Prevotella intermedia Cap. Cephalosporins (200-400 mg )

Pseudomonas aeruginosa 6-12 hourly for 7 days

Staphylococcus spp.

Peptostreptococcus micros Metronidazole (400 mg)


Porphyromonas ednodontalis 5-7 days

Name: Safe in pregnancy


Periapical Pathosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Prevotella melaninogenica Cap. Cephalosporins (200-400 mg) Tab. Metronidazole (400 mg)

Streptococcus anginosus 6-12 hourly for 7 days. 6 hourly for 7 days

Porphyromonas gingivalis

Peptospreptococus

Microbes

Pericoronitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Porphyromonas gingivalis Tab. Penicillin V (250-500 mg) Tab. Penicillin V (250-500 mg)

Fusobacterium species post operative 6 hourly for 5-7 days post operative 6 hourly for 5-7 days

Peptostreptococcus micros

Fusobacterium nucleatum Cap. Doxycycline Initial: (200 mg/day) Tab. Metronidazole (200-400 mg)

divided twice daily post operative first day then orally 8 hourly for 3-5 days

Cap. Cephalosporins

Periodontitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Prohyromonas gingivalis Tab. Metronidazole (200-400 mg) Cap. Cephalosporins (200-4000 mg)
Bacteroides forsythus 8 hourly for 3-5 days 6-12 hourly for 7 days ±

Antinobacillus actinomycente

Prevotella intermedia Cap. Amoxicillin (500 mg) Metronidazole

Fusobacterium nucleatum 6 hourly 5-7 days Amoxicillin

Peptostreptococcus micros

Prevotella oralis Cap. Doxycycline (200 mg)

24 hourly

Primary & secondary prophylaxis for variceal haemorrhage


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Propranolol (20 mg) Tab. Carvedilol (6.25 mg)

Portal Hypertension due to Cirrhosis of liver or non-cirrhotic portal


hypertension

Start at 12 hourly twice a day and titrate up to maximum dose of


24 hourly start with this dose then increase for maintenance up to12.5 mg
320 mg/day.

Prophylaxis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Clindamycin 3 gm prior to surgery

Cap. Amoxicillin (3 gm)prior to surgery.

Cap. Amoxicillin 3 gm prior to surgery

Pulpits
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Obligate anaerobes: Cap. Amoxicillin (500 mg)(preferably with clavulanic acid)or Cap. Cefixime
Peptostreptococcus anaerobius Cap. Cephradine Cap. Cefuroxime

Veillonella parvula Tab. Metronidazole

Lactobacilus cateraforme

Porphylaomonas endodontic

Facultative anaerobes:

Streptococcus mitis

Streptococcus oralis

Enterococcus faucal

Neisseria

Viral infection in lip/oral cavity like herpes simplex infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Acyclovir (400 mg) Tab.Valacyclovir (1 gm)

orally 8 hourly for 7-10 days 12 hourly for 7-10 days

Herpes viruses

Acyclovir ointment for topical application Acyclovir ointment for topical application

Dermatology
Acne Vulgaris
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Azithromycin (500 mg) Cap. Amoxicillin (250-500 mg)

24 hourly 3 days in a week for 12 weeks 8 hourly

Cap. Doxycycline (100 mg) Tab. Trimethoprim-Sulfamethoxazole in double strength


12 hourly for 12 weeks or 12 hourly

Cap. Clindamycin (150 mg)

Propionibacterium Acan 8 hourly and reduced gradually as control is achieved

Cap. Minocycline (50-100 mg)

12 or 24 hourly for 3 months

Cap. Tetracycline (250-500 mg)

6 hourly for 3 months

Erythromycin (250-500 mg)

6 hourly for 3 months

Cellulitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcal Co-amoxiclav (625 mg)

Streptococcal or 8 hourly

Combined

Cap. Flucloxacillin plus Phenoxymethyl penicillin (500 mg)

6 hourly or

Tab. Gatifloxacin (400 mg)


24 hourly for 7 days or

Inj. Ceftriaxone (2 gm) I/V

single or divided dose

Chancroid
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Azithromycin (1 gm) Inj. Ceftriaxone (1 gm) stat dose with Tab. Ciprofloxacin

Oral single dose Tab. Levofloxacin (750 mg)

24 hourly 7 days

Inj. Ceftriaxone (250 mg)

Haemophilus ducreyi
I/M single dose

Tab. Ciprofloxacin (500 mg)

12 hourly for 2 days

Erythromycin (500 mg)

8 hourly for 7 days

Cutaneous Anthrax
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Ciprofloxacin (500 mg)

12 hourly for14 days

Bacillus antharacis

Cap. Doxycycline (100 mg)

12 hourly for 14 days

Cutaneous Tuberculosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Rifampicin (400-600 mg) Inj. Clarithromycin or

single dose Tab. Ofloxacin or

Tab. Ciprofloxacin or

Tab. Isoniazid (300 mg) Inj. Cycloserine or

single dose Inj. Capreomycin or

Tab. Paraaminosalicyclic acid

Tab. Ethambutol (15-25 mg/kg/day) or Tab. Ethionamide.

Inj. Streptomycin (75 mg-1gm)


Mycobacterium Tuberculosis

single dose

Tab. Pyrazinamide (25-35 mg/kg/day)

for 2 months

Tab. Rifampicin (400-600 mg)

single dose

Tab. Isoniazid (300 mg)

single dose for next 4 months

Gonorrhoeae
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Single doses of any of the following orally:

Neisseria gonorrhea
Cap. Cefixime (300 mg)

Neisseria gonorrhea

Tab. Ciprofloxacin (500 mg)

Tab. Ofloxacin (400 mg)

Tab. Levofloxacin (250 mg)

Impetigo contagiosa
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcal Cap. Dicloxacillin (250-500 mg) Tab. Clindamycin (30 mg)

Streptococcal or Tab. Co-amoxiclav (625 mg) 8 hourly

Combined 8 hourly

Cap. Cephalexin (250-500 mg) Cap. Erythromycin (250-500 mg)

6 hourly for 7 days 6 hourly for 7 days

Leprosy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

For paucibacillary: Inj. Clarithromycin (500 mg)

Tab. Dapsone (100 mg) single dose

single dose plus

Cap. Rifampicin (600 mg) Tab. Minocycline (100 mg)

monthly for 6 months single dose

For multibacillary:

Mycobacterium leprae

Tab. Dapsone (100 mg) Tab. Ofloxacin (400 mg)

single dose plus single dose

Tab. Clofazimine (50 mg)


single dose plus Tab. Levofloxacin (500 mg)

Cap. Rifampicin (600 mg) single dose

monthly for 1 year

Syphilis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Doxycycline (100 mg)

12 hourly for 2 weeks

Cap. Erythromycin (500 mg)

6 hourly for 14 days

Inj. Ceftriaxone (250 mg)

Inj. Benzathin penicillin 12 lac unit I/M in each buttock day one
Treponema pallidum
day eight and day fifteenth according to stages

24 hourly I/M or I/V for 8-10 days

Inj. Azithromycin (2 gm)

single dose

Cap. Tetracycline (500 mg)

6 hourly for 14 days

Endocrine System
Sepsis/ Septicemia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (2 gm) Inj. Piperacillin+

Klebsiella 12 hourly at least for 7-10 days Inj. Tazobactam

Streptococcus pyogens Inj. Meropenem

Pseudomonas aeruginosa Inj. Amphotericin-B


Staphylococcus aureus

Skin and soft tissue infection e.g. diabetic foot lesion


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus Tab. Co-Amoxiclav (625 mg) Fluoroquinolones

Streptococcus 8 hourly for 7-10 days Ceftibuten

Anaerobes Inj. Ceftriaxone +

Inj. Clindamycin

Name: Wound care like debridement, regular drening off loading of presure area are much important

Supportive Parotitis (Salivary Gland Infection)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Co-Amoxiclav (1.2 gm) Inj. Clindamycin (900 mg)

8 hourly Oral then: 8 hourly Oral then:

Tab. Co-Amoxiclav (625 mg) Tab. Clindamycin (450 mg)

8 hourly 10-14 days 8 hourly

Gastro Intestinal System


Acute gastroenteritis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Tab. Azithromycin (500 mg) Tab. Ciprofloxacin (500 mg)

Campylobacter 2 tab stat then 1 tab for 4 days 12 hourlyfor 7 days

Shigella

Salmonella Tab. Metronidazole (400 mg)

Clostridium difficile 8 hourlyfor 5-7 days

Name: Pseudomembrenous colities by clostridium difficile is an important cause of gastroenteritis following use of other antibiotics

Abdominal Sepsis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Acinatobacter Inj. Piperacillin/Tazobactam(4.5 gm) Inj. Meropenem (1 gm)

Enterococci faecalis 6-8 hourly for 7-14 days Plus 8 hourly for 7-14 days plus

Bacteroides fragilis

Inj. Amikacin (500 mg) Inj. Amikacin (500 mg)

12 hourly for 7 days Plus 12 hourly for 7 days.

Tab. Metronidazole (500 mg)

8 hourly 7 days

Cholangitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Meropenem (500 mg)

Gram negative anaerobes

8 hourly

Gastroenteritis, Typhlitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Candida Inj. Cefepime (500 mg)

Enterococcus faecalis 8 hourly

Aspergillus

Anaerobes Piperacillin/Tazobactam

Vancomycin

Itraconazole

Name: Liver function test necessary


Necrotizing Pancreatitis (infected)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Piperacillin/Tazobactam (4.5 gm) Inj. Meropenem (1 gm)

6-8 hourly for 7-14 days 8 hourly for 7-14 days plus
Plus Inj. Amikacin (500 mg) Inj. Amikacin (500 mg)

12 hourly for 7 days Plus 12 hourly for 7 days plus

Tab. Metronidazole (500 mg) Inj. Clindamycin (600 mg)

8 hourly 7 days 8 hourly for 7-14 days

Peptic ulcer disease


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Levofloxacin (500 mg) Cap. Tetracycline (500 mg)

12 hourly for 14 to 30 days 6 hourly for 14 to 30 days

Helicobacter pylori

Tab. Metronidazole (400-500 mg)

8 hourly for 14-30 days

Name: Duration depending on the nature and severity of the infection


Secondary bacterial peritonitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Meropenem (500 mg)

Other gut pathogens 8 hourly

Spontaneous bacterial peritonitis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Tab. Levofloxacin (500 mg) Inj. Co-amoxiclav (1 gm/0.2 gm)

Klebsiella 12 hourly for 14 to 30 days 8 hourly for 5 days

Proteus

Tab. Metronidazole (400-500 mg)

8 hourly for 14-30 days


Inj. Cefotaxime(2 gm)

12 hourly for 5 days

Name: Ascitic fluid should be cultured for both aerobic and araerobic organism.

Ascitic fluid should be inculated of blood culture bottle containing 100 ml media of blood culture bottle containing 100 ml media at bed side.

Hepatobiliary system
Amoebic liver abscess
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Metronidazole (750 mg) Nitazoxanide (500 mg)

8 hourly for 5-10 days 12 hourly for 3 days

Entamoeba histolytica

Tinidazole, Orrnidazole (2 gm)

24 hourly for 3 days

Antiviral used in Hepatitis B infection (Chronic Hepatitis B)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Hepatitis B Viris Tab. Tenofovir (300 mg) Tab. Lamivudine (100 mg)

Treatment is indicated: HBV-DNA>2000 IU/ml ALT> Upper limit of


normal Histology= moderate to severe necroinflammation & 24 hourly 24 hourly
significant fibrosis

Tab. Entecavir (0.5 mg) Tab. Adefovir (10 mg)

once daily 24 hourly

Tab.Telbivudine (600 mg)

24 hourly

Inj. PEG-IFN-2a (180 µg)

subcutaneously weekly for 12 months

Antiviral used in Hepatitis C infection (Chronic Hepatitis C)


Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Inj. PEG-IFN+ Tab. Simeprevir+ Cap. Ribavirin Inj. PEG-IFN+ Tab. Sofosbuvir+ Cap. Ribavirin

for 12 weeks for 12 weeks and

Tab. Sofosbuvir+ Cap. Ledipasvir Inj. PEG-IFN+ Cap. Ribavirin

for 12 weeks for next 12 weeks


HCV Genotype 1

Tab. Sofosbuvir+ Tab. Simeprevir

for 12 weeks

Tab. Sofosbuvir+ Tab. Daclatasvir

for 12 weeks

Tab. Sofosbuvir+ Cap. Ledipasvir Inj. PEG-IFN+ Tab. Sofosbuvir+ Cap. Ribavirin

for 12 weeks for 12 weeks and


HCV Genotype 2

Tab. Sofosbuvir+ Cap. Daclatasvir

for 12 weeks

Inj. PEG-IFN+ Tab. Sofosbuvir+ Cap. Ribavirin Tab. Sofosbuvir+ Cap. Ribavirin

for 12 weeks for 24 weeks

HCV Genotype 3

Tab. Sofosbuvir+ Tab. Daclatasvir

for 12 weeks
Inj. PEG-IFN+ Tab. Simeprevir+ Cap. Ribavirin Inj. PEG-IFN+ Tab. Sofosbuvir+ Cap. Ribavirin

for 12 weeks for 12 weeks and

Tab. Sofosbuvir+ Tab. Ledipasvir Inj. PEG-IFN+ Cap. Ribavirin

for 12 weeks for next 12-36 weeks


HCV Genotype 4

Tab. Sofosbuvir+ Tab. Simeprevir

for 12 weeks

Tab. Sofosbuvir+ Tab. Daclatasvir

for 12 weeks

Inj. PEG-IFN+ Tab. Sofosbuvir+ Cap. Ribavirin Tab. Sofosbuvir+ Tab. Daclatasvir

for 12 weeks for 12 weeks

HCV Genotype 5&6

Tab. Sofosbuvir+ Tab. Ledipasvir

for 12 weeks

Cholangitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Piperacillin-Tazobactam (3.375 gm) Inj. Meropenem (1 gm)

Klebsiella Pneumoniae 6 hourly 8 hourly

Pseudomonas

Proteus
Hepatic actinomycosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Actinomyces israelii Benzy1 Penicillin Doxycycline and Clindamycin


Actinomyces israelii Benzy1 Penicillin Doxycycline and Clindamycin

Name: Percutaneous liver biopsy relveals suphaur granules with typical organism

Hydatid disease of liver


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Surgery followed by Tab. Albendazole (400 mg) PAIR followedby Tab. Albendazole (400 mg)

12 hourly for 1 month 12 hourly for 1 month

Echinococcus granulosus

Tab. Albendazole (400 mg)

for 1 month then 14 days interval, total 3-6 cycles

Name: PAIR is as effective as surgery. (WHO guideline- 1996)


Leptospirosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Benzyl Penicillin (900 mg) Inj. Ceftriaxone (1 gm)

Leptospira icterohaemorrhagiae

1.5 million unit 6 hourly for 1 week 24 hourly for 1 week

Name: Blood culture- during limit 10 days or urine culture during 2nd week
Melioidosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftazidime (2 gm) Inj. Meropenem (0.5-1 gm)

8 hourly for 2-3 weeks followed by 8 hourly for 2-3 weeks followed by

Burkholderia pseudomallei

Cap. Doxycycline (200 mg) Cap. Doxycycline (200 mg)

24 hourly plus 24 hourly plus

Tab. Co-trimoxazole (80/400 mg) Co-trimoxazole

Pyogenic liver abscess


Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Escherichia coli Inj. Ciprofloxacin (500 mg) Piperacillin/ Tazobactam

Klebsiella Pneumoniae 12 hourly Imipenem/ Cilastatin

Viridans streptococci Meropenem

Streptococcus Pneumoniae Inj. Ceftriaxone (1 gm) Co-amoxiclav

plus 12 hourly

Inj. Metronidazole for 2 weeks and then oral for 4 weeks.

Infectious Disease
Bacterial vaginosis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Metronidazole (500 mg) Tab. Metronidazole (500 mg)

8 hourly 8 hourly

Anaerobes

Tab. Clindamycin (80 mg) Tab. Clindamycin (80 mg)

8 hourly 8 hourly

Febrile Neutropenia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus Inj. Meropenem (1 gm) Inj. Meropenem (1 gm)

Pseudomonas 8 hourly for 7-10 days 8 hourly for 7-10 days

Streptococcus

Escherichia coli

Klebsiella

Name: Culture sensitivity prefered preceded by emperical treatment


Genital Herpes
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Acyclovir (400 mg) Tab. Famcyclovir (250 mg)

Herpes simplex type I or type II


8 hourly for 7-10 days orally 8 hourly for 7-10 days

Herpes simplex type I or type II

Tab. Valacyclovir (1 gm)

12 hourly for 7-10 days

Kala-azar
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Liposomal Amphotericin B (10 mg/kg) Miltefosine (2.5mg/kg/day)

not less than in 2 hours single dose. in 2 divided doses for 28 days

Paromomycin (15mg/kg/day)

Leishmania

alternate buttock once daily for 21 days

Amphotericin B Deoxycholate (1mg/kg/day)

alternate day total 15 doses

Malaria
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Chloroquine

Tab. Artemether-Lumefantrine- Quinine (10 mg/kg) 8 hourly for 7 Doxycycline


Plasmodium sepsis
days

Tetracycline

Neutropenic fever, Cellulitis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Mostly Unknown Inj. Meropenem (500 mg) Ceftazidime

Gram negative Escherichia coli 8 hourly plusInj Cefepime


Amikacin (500 mg)

I/V 12 hourly for 7 days

Name: ANC <500X10L, Hyperemtivity


Pelvic inflammatory disease
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Azithromycin (1gm)

post operative stat followed by

Tab. Ofloxacin (400 mg)

post operative 12 hourly plus

Tab. Metronidazole (400 mg)

post operative 12 hourly 14 days

Tab. Azithromycin (1 gm)

post operative stat followed by

Inj. Clindamycin (900 mg)

8 hourly plus

Inj. Gentamicin (as per local protocol)

Tab. Clindamycin (450 mg)

post operative 6 hourly Plus

Tab. Ofloxacin (400 mg)


post operative 12 hourly to complete 14 days

Post of Infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Amikacin (500 mg)

Pseudomonas Netlimicin

12 hourly

Post of Infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Ceftriaxone (1 gm)

Escherichia coli Meropenem

24 hourly

Secondary fungal infection e.g. oral thrush


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Candida species Fluconazole plus Locally Nystatin/ Miconazole

Secondary infection in malignant lesion


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas

Staphylococcus
3rd generation Cephalosporins plus Metronidazole 2nd Generation Cephalosporins or Quinolone derivatives

Streptococcus

Sepsis/ Acute PID


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Cephazolin (1gm) (if > 80 kg 2gm)

8 hourly+

Inj. Metronidazole (500 mg)

Gm negative 8 hourly

Inj. Clindamycin (600 mg)

8 hourly +

Inj. Gentamicin (2mg /kg)

8 hourly

Sepsis/ Septicemia
Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Escherichia coli, Klebsiella Inj. Ceftriaxone (2 gm) Inj. Piperacillin + Inj. Tazobactam

Streptococcus pyogens 12 hourly at least for 7-10 days Inj. Meropenem

Pseudomonas aeruginosa Inj. Amphotericin-B

Staphylococcus aureus

Sepsis uncertain focus


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Cefepime (1 gm) Inj. Meropenem (1gm)

8- 12 hourly for 7-14 days 8 hourly for 7-14 days plus

Inj. Vancomycin (1 gm) Inj. Metronidazole (500 mg)

12 hourly 8 hourly for 7 days

Inj. Amikacin (500 mg)

12 hourly for 7 days Plus

Inj. Metronidazole (500 mg)

8 hourly for 7 days

Septicemia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Meropenem (1 gm) Inj. Piperacillin/ Tazobactam (4.5 gm)

According to source of infection

6 hourly 8 hourly

Sick Immunocompromised (febrile neutropenia)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Meropenem (1 gm) Inj. Linezolid (600 mg)


8 hourly for 7-14 days or/plus 12 hourly or/plus

Inj. Meropenem (1 gm) Inj. Piperacillin/Tazobactam (4.5 gm)

8 hourly for 7-14 days or/plus 6-8 hourly for 7-14 days

Quinolone

7-14 days

Trichomoniasis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Metronidazole (2 gm) as a single oral dose or (400 mg) Tab. Metronidazole (2 gm) as a single oral dose or (400 mg)

12 hourly for 7 days. Or 12 hourly for 7 days. Or

Trichomoniasis vaginalis Tinidazole (2 gm) Tab. Tinidazole (2 gm)

as a single oral dose Or as a single oral dose Or

Secnidazole (2 gm) Tab. Secnidazole (2 gm)

single dose for both partners single dose for both partners

Uncomplicated Chlamydial Infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

If poor compliance: Inj. Clarithromycin or

Tab. Azithromycin (1 gm) Tab. Ofloxacin or

post operative stat dose

If Pregnant:
Tab. Erythromycin (500 mg)

post operative 6 hourly for 7 days or

Tab. Erythromycin (500 mg)

post operative 12 hourly for 14 days

Valvovaginal Candidiasis (non regnant)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Tab. Clotrimazole (500 mg) aginal tab once Or Two (100 mg)
Tab. Clotrimazole (500 mg) vaginal tablet once Or Two (100 mg) vaginal tablet topically
vaginal tablet topically

Candida Albicans

for 3 nights Or Vaginal 1% cream topically for 6 nights for 3 nights Or Vaginal 1% cream topically for 6 nights

Cap. Fluconazole (150 mg) Cap. Fluconazole (150 mg)

as a single dose oral as a single dose

Name: Contraindicated in pregnancy


Venous aseptic site of infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus epidermises Inj. Ceftriaxone (1-2 gm) <

Staphylococcus aureus 12 hourly Inj. Cephalosporins

Pseudomonas Inj. Amikacin

Inj. Amikacin (500 mg) Tab. Linezolid

12 hourly Cap. Flucloxacillin


Tab. Ciprofloxacin

Name: Sterelity should be strictly maintained. Personal hygine of the patient as well as hospital stuff should be maintained

Venous harvesting site wound infection of leg


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus aureus Inj. Ceftriaxone (1-2 gm) Inj. Cephalosporins

Streptococcus pyogens 12 hourly Inj. Amikacin

Pseudomonas Tab. Linezolid

Escherichia coli Inj. Amikacin (500 mg) Cap. Flucloxacillin

12 hourly Tab. Ciprofloxacin

Name: Sterelity should be strictly maintained. Personal hygine of the patient as well as hospital stuff should be maintained

VTI, Septicemia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Gram positive Inj. Ceftriaxone (1 gm)

Staphylococcus aureus 24 hourly

Pseudomonas

Inj. Imipenem (500 mg-1gm)

8 hourly

Name: Steroid coverage with antimicrobial therapy may be required


Wound infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Cream Gentamicin apply locally 2-3 times daily Or

Staphylococcus aureus Cream/ointment Fusidic acid apply locally 2-3 times daily Or
Pseudomonas Cream/ointment Mupirocin apply locally 2-3 times daily Or

Combination of Bacitracin and neomycin apply the cream locally 2-


3 times daily Fusidic acid is a steroid antimicrobial agent which is
Klebsiella
used almost exclusively against β lactamase producing
staphylococci

Kidney and Urinary System


Acute Pyelonephritis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Tab. Ciprofloxacin (500 mg) Inj. Ceftriaxone (1 gm)

Streptococcus saprophyticus 12 hourly for 7 days stat dose with oral Ciprofloxacin

Klebsiella

Tab. Trimethoprim- Sulfamethoxazole 1 double strength tablet


Pseudomonas aeruginosa Inj. Levofloxacin (750 mg)
(160/800 mg)

Enterococci 12 hourly for 3 days 24 hourly for 7 days

Name: Complicated pyelorephritis are common in diabetic patient require prolong therapy

ESWL
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Fluoroquinolones Inj. Aminoglycosides

TMP/SMX Tab. Amoxicillin

1st/2nd generation Cephalosporins

Lower urinary tract infection (cystitis) in pregnancy UTI


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Escherichia coli Cap. Nitrofurantoin (100 mg) Cap. Cephalexin (500 mg)

Klebsiella 6 hourly for 7 days 8 hourly for 7 days

Pseudomonas

Enterococcus Tab. Pivmecillinam (400 mg) stat & (200 mg)

8 hourly for 7 days

Non Gonococcal Urethritis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Chlamydia trachomatis Cap. Doxycycline (100 mg) Cap. Erythromycin (500 mg)

Ureplasma urealyticum 12 hourly for 7 days 6 hourly for 7 days or 12 hourly for 2 weeks or

Mycoplasma

Genetalium Tab. Azithromycin (1 gm) Tab. Ofloxacin (200 mg)

single dose 12 hourly for 7 days

PCNL
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

1st/2nd generation Cephalosporins or Aminoglycosides

Inj. Aminoglycosides Fluoroquinolones

Tab. Metronidazole or Clindamycin

Prostatitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli

Enterobacteriaceae

TMP/SMX for 4 weeks Fluoroquinolones


Pseudomonas
TMP/SMX for 4 weeks Fluoroquinolones

Enterococci

Enterococcus

Prostatic biopsy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Fluoroquinolones TMP/SMX

1st/2nd generation Cephalosporins Aminoglycosides

Surgical prophylaxix: Urethrocystoscopy, Urodynamic study, Ureteroscopy, TURP, TURBT


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Fluoroquinolones Inj. Aminoglycosides

TMP/SMX Inj. Ampicillin

1st/2nd generation Cephalosporins

Co-Amoxiclav

Urinary Tract Infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Tab. Ciprofloxacin (500 mg) Co-amoxiclav

Klebsiella 12 hourly for 7-10 days Cefuroxime+Clindamycin

Pseudomonas

Staphylococcus aureus

Candida albicans

Urinary Tract Infection (acute uncomplicated cystitis)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Tab. Nitrofurantoin (100 mg) Fluoroquinolones

Streptococcus saprophyticus 12 hourly for 5 days Tab. Ofloxacin (400 mg)

Klebsiella 12 hourly for 3 days


Tab. Trimethoprim- Sulfamethoxazole 1 double strength tablet
Pseudomonas aeruginosa Tab. Ciprofloxacin (250 mg)
(160/800 mg)

12 hourly for 3 days 12 hourly for 3 days

Tab. Levofloxacin (500 mg)

Fosfomycin trometamol (3 gm) 24 hourly for 3 days

A sachet orally a single dose β-Lactams

Co-amoxiclav

Pivmecillinam (400 mg) Cefdinir

12 hourly for 3-7 days Cefaclor

Cefpodoxime-Proxetil (100mg)

12 hourly 3 days

Urosepsis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Amikacin (500 mg) Inj. Cefepime (1 gm)

Proteus 12 hourly for 7 days 8-12 hourly for 7-14 days

Klebsiella

Enterococci Inj. Meropenem (1 gm) Inj. Meropenem (1 gm)

Candia 8 hourly for 7-14 days plus 8 hourly for 7-14 days or plus

Cap. Fluconazole (500-100 mg/day) if fungal infection Cap. Fluconazole (500-100 mg/day)
Urological Surgery involving intestine e.g.: GI tract, Skin+ intestine
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

2nd/3rd generation Cephalosporins Inj. Ampicillin

Inj. Aminoglycosides Inj. Ticarcillin/ Co-Amoxiclav

Tab. Metronidazole or Inj. Piperacillin/ Tazobactam

Clindamycin Fluoroquinolones

Musculoskeletal system
Acute and chronic pyogenic Osteomyelitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus aureus Inj. Ceftriaxone (1 gm) Inj. Cefuroxime (750 mg)

Staphylococcus pyogens 12 hourly 12 hourly

Inj. Flucloxacillin (250 mg-1 gm)

6 hourly

Deep sternal wound infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus pyogens Inj.Meropenem (500 mg-1 gm) Inj. Ceftriaxone

Streptococcus aureus 18 hourly Inj. Amikacin

Pseudomonas Inj. Flucloxacillin

Escherichia coli Inj. Amikacin (500 mg) Inj. Linezolid

Fungal 12 hourly Inj. Ciprofloxacin

Name: Sterctity should be strictly maintained. Personal hygine of the patient as well as hospital stuff should be maintained superficial and deep

Elective Surgery
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (1 gm)

12 hourly
Inj. Cefuroxime (750 mg)

12 hourly

Inj. Cefepime(500 mg-1000 mg)

8 hourly
Prophylactic purpose

Inj. Flucloxacillin (250 mg -1000 mg)

6 hourly

Inj. Amikacin (500 mg)

12 hourly any one or two in combination

Septic arthritis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus aureus Inj. Ceftriaxone (1 gm)

Haemophilus influenza 12 hourly

Enterobacter Species

Inj. Flucloxacillin (250 mg-1 gm)

12 hourly

Name: Preferred culture sensitivity report


Skin & Soft tissue infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus pyogens

Cap. Flucloxacillin (500mg) 6 hourly Tab. Clarithromycin (500mg) 12 hourly and Cap. Clindamycin (450-60mg) 6 hourly

Staphylococcus aureus

Superficial sternal wound infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus aureus Inj. Ceftriaxone (1-2 gm) Inj. Cephalosporins


Streptococcus pyogens 12 hourly Inj. Amikacin

Escherichia coli Inj. Flucloxacillin

Pseudomonas Inj. Amikacin (500 mg) Inj. Linezolid

12 hourly Inj. Ciprofloxacin

Name: Sterctity should be strictly maintained. Personal hygine of the patient as well as hospital stuff should be maintained superficial and deep

Tubercular Osteomyelitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Mycobacterium aureus 1st line anti-tubercular drugs

Wound infections
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus aureus Inj. Ceftriaxone (1 gm)

Pseudomonas pyogenosa 12 hourly

Klebsiella

Enterobacteriaceae Inj.Meropenem (500 mg)

8 hourly

Inj. Amikacin (500 mg)

2 hourly

Inj. Flucloxacillin

Name: According to culture sensitivity report


Obstetrics and Gynaecological Procedure
D&C, endoscopic or other minor procedure
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Anaerobes Not needed


Caesarean section
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Amoxiclav (1.2 gm) Inj. Clindamycin (900 mg)

Prophylaxis

8 hourly 8 hourly

Name: Review culture reports


Infected wound Caesar/ Perineal tear and episiotomy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Gram negative Inj. Flucloxacillin (900 mg)


Staphylococcus 8 hourly+

Escherichia coli

Pseudomonas Inj. Metronidazole (500 gm)

8 hourly followed by oral for 7 days

Intra partum pyrexia


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Amoxicillin (2 gm) + Inj. Metronidazole (500 mg) initially


followed by

Inj. Amoxicillin (500 mg)

8 hourly +

Prophylaxis Inj. Clindamycin in penicillin allergy group


Inj. Metronidazole (500 mg)

8 hourly till delivery

Inj. Gentamicin if severe sepsis 5 days for oral antibiotics after


delivery

Placenta Removal,4 Degree Tear, Major Surgery, Extensive Oncological Surgery


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

IV-single dose only at induction

Post operative Gynaecological Sepsis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Gentamicin (as per local protocol) plus Inj. Clindamycin (1.2
gm)

6 hourly
Stop and review if patient develops diarrhoea or if Gentamicin is
contra-indicated ( see GHNHSFT protocol ) consult microbiologist
Duration: 5-7 days and then review

Non-severe penicillin Allergy:

Inj. Meropenem (1 gm)

8 hourly

Severe penicillin Allergy:

Inj. Gentamicin (as per local protocol) plus

Inj. Clindamycin (1.2 gm)

6 hourly

Stop and review if patient develops diarrhoea or if Gentamicin is


contra-indicated ( GHNHSFT protocol ) consult microbiologist.
Duration: 5-7 days and then review. Consult Microbiologist

Prophylaxis Hysterectomy Laparotomy Vaginal Repair


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (2 gm) Inj. Cephazolin (1gm) (if >80 kg 2 gm)+

12 hourly at least for 7-10 days Inj. Metronidazole (500 mg)

8 hourly

Inj. Clindamycin (600 mg) + Inj. Gentamicin (2 mg /kg)


8 hourly

Name: If no penicillin or B-lactuse allergy


Surgical Prophylaxis Obstetric & Gynaecological Surgery Hysterectomy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

IV-single dose only at induction

Opthalmology
Antibiotics used in surgical prophylaxis: Cataract surgery, Glaucoma surgery, Dacryocystitis (Chronic)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Moxifloxacin 0.3%

Levofloxacin 0.3%

Gatifloxacin 0.3% 1 drop g.i.d.

Bacterial Uveitis

Likely causative agent Antimicrobial of choice


Preferred drug
Alternative drug

Mycobacterium tuberculosis According to cause

Mycobacterium Bovis Anti-TB

Treponema. pallidum Anti-Syphilis (systemic regimen to be followed)

Name: Aquaus and vitreous sample for culture sensitivity


Conjunctivitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumonia Chloramphenicol Tetracycline

Staphylococcus aureus Aminoglycosides (Gentamicin, Neomycin) Fusidic acid

Haemophilus influenzae Quinolones (Ciprofloxacin Ofloxacin) Doxycycline

Moraxella catarrhalis Levofloxacin Erythromycin

Neisseria gonorrhea Lomefloxacin Bacitracin

Neisseria meningitides Gatifloxacin


Chlamydia trachomatis Moxifloxacin

Polymyxin B

Fusidic acid dose (g.i.d. for 1 week)

Name: Conjunctival culture sensitivity needed


Corneal Ulcer
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas Ciprofloxacin 0.3% Moxifloxacin

Staphylococcus aureus Ofloxacin 03.% Gatifloxacin

Streptococcus Fortified Gentamicin Doxycycline

Neisseria Gonorrhoeae Fortified Cephalosporins Tetracycline

Procaine Penicillin (g.i.d. for 1 week or according to severity of the


Meningitis Erythromycin
disease)

Coronibacterium diphtheria Sub conjunctival antibiotics

Haemophilus influenzae

Treponema pallidum

Name: Depends on culture sensitivity. Conjunctival sweab and corneal serapping


Dacryocystitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus aureus Flucloxacillin (oral) Co-amoxiclav

Epidermidis for 1 week Cephalosporins

Streptococcus viridians Cefixime

Pneumoniae pyogens Cephradine


Escherichia coli

Name: Depending on culture sensitivity


Endophthalmitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus species. Ceftazidime (2 mg in 0.1 ml) Amikacin (0.4 mg in 0.1 ml)

Bacillus species Vancomycin (2 mg in 0.1 ml) Gentamicin (0.2 mg in 0.1 ml)

Tab. Ciprofloxacin (750 mg)

12 hourly or

Moxifloxacin (400 mg)

24 hourly

Name: Aquaus vitreous sample for culture sensitivity


Lid infection
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococcus aureus Ciprofloxacin 0.3% 1 drop g.i.d Moxifloxacin

Pyogenes for 7 days (dose can be readjusted according to severity) Flucloxacillin

Epidermidis

Streptococcus viridans

Pneumonia

Pyogenes

Name: To maintain lid hygine


Neonatal conjunctivitis (Opthalmia Neonatorum)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Chlamydia trachomatis Penicillin G Topical 1,00,000-3,33,000 units/ml

Silver nitrate 1% solution

Neisseria Gonorrhoeae Paediatric 10,000 to 20,000 IU

Orbital Cellulitis
Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Streptococcus Pneumoniae Ceftazidime I/V (2mg in 0.1ml)

Oral Metronidazole (antibiotic continued) till the patient free


Staphylococcus aureus
from fever

Vancomycin (if penicillin allergy) 1 mg in 0.1 ml

Streptococcus viridans for 4 days.

Haemophilus influenzas

Name: Pus for culture sensitivity if orbital obsess prerent


Syphilitic eye disease, Syphilitic Uveitis, Optic neuritis, Neuroretinitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

3 to 4 million unit Penicillin G is administered every Alternative procaine Penicillin G IM 2.4 million IU daily plus Probenecid (500 mg)

Treponema pallidum

4 hourly for 10 to 14 days. oral g.i.d for 10 to 14 days.

Paediatric Central Nervous System


Central venous catheter tip Micro organism isolated: 75%
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas 66.66% Imipenem (20 mg/kg/dose)

Staphylococcus aureus 33.33% 8 hourly

Tazobactam + Piperacillin

8 hourly

Meningitis in Children (Bacteria), Young infant


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Neisseria meningitides Inj. Ceftriaxone (100 mg/kg/day) Meropenem (40 mg/kg/day)

Streptococcus pneumonia 12 hourly + 8 hourly+

Haemophilus influenjae

Inj. Dexamethasone (0.15 mg/kg/day) Amino glycosides (if pseudomonas)

every 6 hourly for 48 hours started at least 20 minutes before


antibiotic therapy

Inj. Cefotaxime (200 mg/kg/day)

8 hourly for 10 days+

Inj. Vancomycin (45-60 mg/kg/day)

8 hourly for 10 days+

Ampicillin (200-400 mg/kg/day)

6 hourly for 10 days

Septicemia CNS infection


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Vancomycin (45-60 mg/kg/day) Inj. Vancomycin (45-60 mg/kg/day)

12 hourly for 10-14 days+ 12 hourly for 10- 14 days+

Organism of unknown susceptibility


Organism of unknown susceptibility

Inj. Meropenem (30-40 mg/kg/day) Inj. Meropenem (30-40 mg/kg/day)

8 hourly for 10-14 days 8 hourly

Paediatric Gastrointestinal System


Bacillary dysentery

Likely causative agent Antimicrobial of choice


Preferred drug
Alternative drug

Cap. Cefixime (8-10 mg/kg/day) Cefixime12 hourly

12 hourly for 5 days Ceftriaxone (50-75 mg/kg/day)

Shigella species, Shigella dysentery, Shigella flexnari


12 hourly

Pivmecillinam (50 mg/kg/day)

6 hourly for 5 days

Cholangitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Ceftazidime (150 mg/kg/day)

Meropenem (30-40 mg/kg/day)

Staphylococcus aureus Amikacin (15-20 mg/kg/day)

Diarrhoea
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Azithromycin (10 mg/kg/day)

Ceftriaxone (50-200 mg/kg/day)


Shigella Ciprofloxacin (15-30 mg/kg/day)

Vibrio cholerae Pivrnecillinam

Enteric Fever & Severe Enteric Fever


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Salmonella typhi Cap. Cefixime (20 mg / kg/day) Azithromycin (20 mg/kg/day)


Salmonella paraphyphi A 12 hourly for 10 to 14 days 24 hourly 7 days

Salmonella paratyphi B

Inj. Ceftriaxone (50-75 mg/kg/day) Ciprofloxacin (20-30 mg/kg/day)

12 hourly at least 5 days after a febrile period 12 hourly 7-10 days

Inj. Ceftriaxone (50-75 mg/kg/day)

Inj. Dexamethasone (3mg/kg)initial flowed by (1 mg/kg)

6 hourly for 48 hours

Giardiasis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Metronidazole (15 mg/kg/day)

Giardia Secnidazole

8 hourly for 5–7 days

Hydatid cyst
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Echinococcus Albendazole (15 mg/kg/day)

Granulosus 12 hourly

Intestinal Amoebiasis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Entamoeba Metronidazole (15 mg/kg/day)

Secnidazole
Secnidazole

Histolytica 8 hourly for 5–7 days

Liver Abscess
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus aureus Ceftriaxone (50-200 mg/kg/day)

Gram negative Flucloxacillin (50-100 mg/kg/day)

Anaerobic organism Metronidazole

Peritonitis (Ascitic Fluid C/S) Micro organism isolated:4%


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumoniae Ceftazidime (50 mg/kg/dose)

Acinetobactor 8 hourly

Escherichia coli

Ceftriaxone (100 mg/kg/day)

12-24 hourly

Amikacin (7.5 mg/kg/dose)

12 hourly

SBP
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Cefotaxime (50-200 mg/kg/day)

Meropenem (30-40 mg/kg/day)

Staphylococcus aureus Flucloxacillin (50-100 mg/kg/day)

Paediatric Infectious Disease


Abscess 2%
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Flucloxacillin (25-250 mg) Inj. Vancomycin (45-60 mg/kg/day)

Enterobacter Spesis
6 hourly 12 hourly for 10-14 days+

Enterobacter Spesis

Vancomycin (45-60 mg/kg/day) Inj. Meropenem (30-40 mg/kg/day)

Tazobactam 8 hourly

Meropenem (30-40 mg/kg/day)

Oral thrush
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Nystatin (4-6 lakhs) Inj. Vancomycin (45-60)

unit for 6 hourly 8 hourly for 2-4 weeks

Candida albicans

Miconazole 2% apply

12 hourly

Septicemia (Blood C/S) 10%


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Klebsiella Inj. Amikacin (15-20 mg/kg/day) Gentamicin

Acinatobacter Inj. Meropenem (30-40 mg/kg/day) Amikacin

Coagulase negative staph Inj. Ceftazidime (150 mg/kg/day) Imipenem

Escherichia coli Colistin

Ciprofloxacin

Cotrimoxazole

Vancomycin

Netlimicin

Name: Febrile Neutropenia in Paediatric Haematology and Oncology is considered as an entity which is to be addressed ifferently. Here the practised protocol is-

1st line- 3rd generation of Cephalosporin + Amikacin


2nd line- 4th generation of Cephalosporin or Carbapenem + Vancomycin

If febrile neutropenia persists 5-7 days or more we start intravenous Amphotericin B


Septicemia (Blood C/S) Micro organism isolated:6%
Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Escherichia coli Cefotaxime (50 mg/kg/dose)

Salmonella 8-12 hourly

Enterococcus

Pseudomonas Ampicillin (25 mg/kg/dose)

Klebsiella 6 hourly

Vancomycin (15mg/kg/dose)

8 hourly

Ceftazidime (50 mg/kg/dose)

8 hourly

Amikacin (7.5 mg/kg/dose)

12 hourly

Septic Arthritis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Haemophilus influenza Inj. Ceftriaxone (50-75 mg/kg/day) Inj. Clindarnycin (10-40 g/kg/day)

Streptococcus aureus 12 hourly for 4 weeks 8 hourly

Streptococcus pneumoniae

Cefotaxime (20 mg/kg/day) Vancomycin (45-60 mg/kg/day)

8 hourly for 4 weeks+ 8 hourly

Clindamycin (10-40 mg/kg/day) Meropenem (40 mg/kg/day)

8 hourly for 4 weeks 8 hourly

Skin infection Cellulitis Osteomyelitis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cloxacillin (50-100 mg/kg) Inj. Vancomycin (45-60)

6 hourly for 7-10 days 8 hourly for 2-4 weeks

Organism of unknown susceptibility

Inj. Clindamycin (10-40 mg/kg/day)

8 hourly for 2-4 weeks

Throat Swab Micro organism isolated: 12%


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus pyogens 82% Penicillin (25-50 mg/kg/dose)

Staphylococcus aureus 18% 6 hourly

Erythromycin (10 mg/kg/dose)

6 hourly

Amoxicillin (25 mg/kg/dose)

8 hourly

Clindamycin (3-6 mg/kg/dose)

6 hourly

Wound Swab 2%
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Flucloxacillin (125-250 mg) Imipenem

6 hourly Amikacin

Colistin

Amikacin (15-20 mg/kg/day) Ticarcillin

Pseudomonas

Meropenem (30-40 mg/kg/day)


Pseudomonas

Vancomycin (45-60 mg/kg/day)

Paediatric Surgery
Amniotic band of both leg: release of bank and Z-plasty in right leg
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococci Inj. Ceftriaxone (50-75 mg/kg/day)

Micrococci Inj. Flucloxacillin(50-100 mg/kg/day) followed by Flucloxacillin

Gram positive rods

AVM at the root of nose: Excised


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (50-75 mg/kg)

AVM of left thigh (Aspirated) (Aspirated fluid: no growth)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococci

Micrococci Inj. Cephradine (50-100 mg/kg/day)

Gram positive rods

Cystic Hygroma (within the abdomen) with sliding hernia: Excision of Cystic hygroma with herniotomy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Inj. Flucloxacillin (50-100 mg/kg/day) followed by Cefixime (20


Klebsiella
mg/kg/day)

Pseudomonas aeruginosa

Enterococci

Discharging sinus at penoscrotal region: Excision (Pus for C/S: Pseudomonas spp.)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Klebsiella Tab/Inj. Ciprofloxacin (10 mg/kg/day)

Pseudomonas aeruginosa Inj. Amikacin (15-20 mg/kg/day) followed by

Proteus Inj. Imipenem (60-100 mg/kg/day)

Name: During change to other group of antibiotic require further urine culture sensitivity

Eventration of left dome of diaphragm with umbilical hernia: Plication of the defect and repair of hernia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Klebsiella Pneumoniae Inj. Gentamicin (5 mg/kg/day)

Streptococci Pseudomonas

Enterococci

Growth in lower Esophagus: feeding gastrostomy with biopsy from growth


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Cephradine (50-100 mg/kg/day)

Klebsiella pneumonia Inj. Gentamicin (5 mg/kg/day)

Streptococcus pneumonia

Enterococci

Hydrocephalus and Meningomyelocele with urinary and fecal incontinence; Introduction of V-P shunt with excision of meningomyelocele
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftazidime (15-20 mg/kg/day)

Encapsulated organism: Streptococcus Pneumoniae, Nigeria


meningitides, Haemophilus influenza. Non capsulated organism:
Listeria monocytogenes
Encapsulated organism: Streptococcus Pneumoniae, Nigeria
meningitides, Haemophilus influenza. Non capsulated organism:
Listeria monocytogenes

Inj. Amikacin (15-20 mg/kg/day)

Hypospaedias with rotational deformity of penis: Urethroplasty and correction of rotation


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day) followed by

Klebsiella Inj. Meropenem (30-40 mg /kg/day)

Pseudomonas aeruginosa Inj. Flucloxacillin (50-100 mg/kg/day)

Proteus Inj. Amikacin

Name: Multidrug use of antibiotic also require specific indication


Hypospaedias: Urethroplasty
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (50-75 mg/kg/day) Streptococcus pyogens 82%

Escherichia coli, Klebsiella, Pseudomonas aeruginosa, Proteus

Inj. Flucloxacillin (50-100 mg/kg/day) followed by Cefixime ( 20 mg


Staphylococcus aureus 18%
/ kg/day)

Long segment Hirschsprung’s Disease with Ileostomy: Total colectomy with ileo-anal anaestomosis. On 7th POD patient developed incomplete wound dehiscence which closed by secondary suture
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Bactericides Fragilis Inj. Metronidazole (15- 30 mg/kg/day)On 3rd POD added


Inj. Ciprofloxacin (10 mg/kg/day) due to development of loose
Streptococcus viridians group
diarrhoea. On 26th POD: Changed to

Inj. Meropenem (30-40 mg/kg/day)

Inj. Amikacin (15-20 mg/kg/day)

Name: Frequent changes of antibiotic so require wound sweab. Specific indication should mentioned

Mass in right gluteal region: Incisional biopsy


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus pyogens 82%

Staphylococci, Micrococci, Gram positive rods Inj. Ceftriaxone (50-75 mg/kg/day) followed by oral Cefixime

Staphylococcus aureus 18%

Meconium ileus with Ileostomy: Ileostomy closure (Stool culture: no organism)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli, Bactericides Fragilis Inj. Ceftriaxone (50-75 mg/kg/day)

Streptococcus viridians group Inj. Metronidazole

Inj. Amikacin

Non-operative case of Choledochal cyst


Likely causative agent Antimicrobial of choice

Inj. Ceftriaxone (50-75 mg/kg)

Penoscrotal hypospaedias: Urethroplasty (Urine c/s: no growth)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)


Klebsiella pneumonia Inj. Flucloxacillin (125-250 mg/kg/day) followed by oral Cefixime

Pseudomonas aeruginosa

Proteus
Perineal hypospaedias with bilateral undescended testes: Urethroplasty with bilateral orchiopexy (Urine c/s: no growth)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (50-75 mg/kg/day) for 7 days, Then Inj.


Meropenem(30-40 mg/kg/day), Inj. Flucloxacillin (50-100
mg/kg/day) and Inj. Amikacin (15-20 mg/kg/day) for 8 days
followed by Syrup Cefixime ( 20 mg / kg/day)
Escherichia coli, Klebsiella, Pseudomonas aeruginosa, Proteus

for 16 days.

Rectourethral fistula: Perineal hole technique anoplasty (Urine C/S: No. growth)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Bactericides Fragilis Inj. Metronidazole (15-30 mg/kg/day)

Streptococcus viridians group Inj. Ceftazidime (150 mg/kg/day)

Inj. Gentamicin (5 mg/kg/day)

Residual PUV with Left sided VUR: Fulgaration with left sided ureteric re-reimplantation Ruine R/M/E: Normal finding (Urine C/S: no organism)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day) followed by

Klebsiella Inj. Meropenem (30-40 mg/kg/day)


Pseudomonas aeruginosa Inj. Amikacin

Proteus
Thalasseaemia with Hypersplensim: Splenectomy
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Inj. Ceftriaxone (50-75 mg/kg/day)

Klebsiella Pneumoniae Inj. Phylopen

Streptococci Pseudomonas Inj. Amikacin (15-20 mg/kg/day)

Enterococci

Paediatric Urinary System


Urinary tract infection Acute cystitis Acute pyelo nephrities
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Escherichia coli Cap. Cefixime (8-10 mg/kg/day) Inj. Amikacin (15-20 mg/kg/day)

Klebsiella 12 hourly for 7-10 days Inj. Gentamicin (5 mg/kg/day)

Proteus Cap. Nitrofurantoin (5-7 mg/kg/day)

Tab. Ciprofloxacin (8-30 mg/kg/day) Tab. Co-trimoxazole

12 hourly for 7-10 days

Inj. Amikacin (15-20 mg/kg/day)

Inj. Gentamicin (5 mg/kg/day)

Ceftazidime (150 mg/kg/day)

Urinary tract infection (UTI) Micro organism isolated: 6%


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Escherichia coli Cefotaxime (50 mg/kg/dose)

Enterococci 8-12 hourly

Acinatobacter

Pseudomonas Ceftazidime (50 mg/kg dose)

8 hourly

Ceftriaxone (100 mg/kg days)

12-24 hourly

Nitrofurantoin (1.75 mg/kg dose) 6 hourly

Amikacin (15 mg/kg dose)

12 hourly

Gentamicin (2.5 mg/kg/day)

8 hourly

Recurrent UTI prophylaxis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Nitrofurantoin (1-2 mg/kg/day)

Single dose at bed time

Tab. Co-trimoxazole (6-20 mg/kg/day)

single dose at bed time

Paediatrics Respiratory System


Otitis Media 2%
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
Ceftriaxone (50-75 mg/kg/day) Ceftazidime

Cefuroxime Ciprofloxacin

Pseudomonas

Ceftazidime (150 mg/kg/day) Imipenem

Meropenem

Netlimicin

Pneumonia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Haemophilus influenjae Inj. Ceftriaxone (50-75 mg/kg/day) Inj. Ceftriaxone (50-75mg/kg/day)

Staphylococcus aureus 7-10 days according to clinical response 12 hourly

Nosocomial:

Escherichia coli Cap. Flucloxacillin (125-250 mg) Inj. Gentamicin (5 mg/kg/day)

Streptococcus Pneumoniae 6 hourly.(in staphylococcus aureus) 3 hourly

Haemophilus influenjae

Pseudomonas Inj. Azithromycin (10 mg/kg/day) Inj. Clarithromycin (15 mg/kg/day)

Klebsiella Inj. Erythromycin (30-50 g/kg/day) 8 hourly

Staphylococcus aureus

Community acquired: Inj. Clindamycin (10-40 g/kg/day)

≥5 years: Mycoplasma Chlarnydia 8 hourly for 14 days


Inj. Vancomycin (45-60 g/kg/day)

8 hourly

Inj. Imipenem (15-25 mg/kg/day)

8 hourly

Inj. Clarithromycin (15 mg/kg/day)

RTI 4%
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Klebsiella Penicillin (125-250 mg) Imipenem

Acinatobacter orally every 6-8 hourly Ciprofloxacin

Colistin

Erythromycin (30-50 mg/kg/day) Tazobactam

Clarithromycin (15 mg/kg/day) Piperacillin

Meropenem (30-40 mg/kg/day)

Respiratory System
Acute Bacterial Rhino sinusitis (severe or persistent symptoms)
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Gram positive: 1st line: 1st line:

Staphylococcus aureus Tab. Co-Amoxiclav (625 mg) Inj. Clarithromycin (500 mg)

Streptococcus Pneumoniae 8 hourly orally 12 hourly

Haemophilus influenzae 2nd line: 2nd line:

Pseudomonas aeruginosa Doxycycline oral(100 mg) Cap. Doxycycline (100 mg)


Moraxella catarrhalis 12 hourly 10 days 12 hourly

Gram negative:

Pseudomonas aeruginosa

Escherichia coli

Protease mirabilis

Klebsiella Pneumoniae

Enterobacter

Acute Diffused Otitis Externa (Swimmer's ear)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Staphylococus aureus Mile-moderate:

Pseudomonas pyogens Cap.Flucloxacillin Topical Antimicrobial

Escherichia coli Severe (e.g. Cellulitis or blocked ear canal):

Often mixed flora Inj. Ceftriaxone (1 mg)

Tab. Ciprofloxacin (500mg)

12 hourly for 7-10 day

Name: Topical drops to be prescribed at the discretion of the ENT consultant


Acute Laryngitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Antibiotics are NOT Indicated

Acute Localised Otitis Externa (furuncle)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Cap. Flucloxacillin (1 gm) Clarithromycin (500 mg)

Staphylococcal 6 hourly for 7 days plus 12 hourly


Staphylococcal

Topical steroids

Acute Otitis Media


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Antibiotics should not be routinely prescribed for uncomplicated Antibiotics should not be routinely prescribed for uncomplicated AOM. For severe
Streptococcus Pneumoniae
AOM. For severe disease or when risk of complications: disease or when risk of complications:

Staphylococcus aureus

Haemophilus influenzae 1st Line 1st Line

Micrococcus Catarrhalis (Necrotizing)

B Haemolytic streptococcus Cap. Amoxicillin (500 mg) Clarithromycin (500 mg)

8 hourly 12 hourly

2nd line 2nd line

Tab. Co-Amoxiclav (625 mg) Cap. Doxycycline (100 mg)

8 hourly 10 days 12 hourly and

Tab. Metronidazole (400 mg)

8 hourly

Name: Most cases are viral and self limiting. Antibiotics should be delayed for 2-3 days and patient response

Acute Rhino Sinusitis


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Antibiotics should be Only prescribed in SEVERE infection. Mostly


this condition caused by viral

Aspiration pneumonia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas Inj. Piperacillin/Tazobactam(4.5 gm) Inj. Meropenem (1gm)


Acinatobacter 6-8 hourly for 7-14 days plus 8 hourly for 7-14 days

Enterococci faecalis

Bacteroides fragilis Inj. Amikacin (500 mg) Inj. Amikacin (500 mg)

12 hourly for 7 days Plus 12 hourly for 7 days plus

Tab. Metronidazole (500 mg) Tab. Clindamycin (600 mg)

8 hourly for 7 days 8 hourly for 7-14 days

Chronic Otitis Media


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Aerobic:

Pseudomonas aeruginosa

Escherichia coli

Streptococcus aureus

Streptococcus Pyogenes

Oral antimicrobial may be added if a susceptible organism is


cultured 7-10 days

Proteus mirabilis

Klebsiella species

Anaerobic:

Bacteroides

Peptostreptococcus

Propionibacterium

Community Acquired Pneumonia (CAP)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumoniae Inj. Azithromycin (500 mg) I/V OD Inj. Ceftazidine (1 gm)

Staphylococcus aureus 5 days, or 8 hourly for 7-14 days, plus/ or

Candia
Inj. Clarithromycin (500 mg) Inj. Clindamycin (600 mg)I/V

12 hourly for 7-14 days 8 hourly for 7-14 days

Inj. Quinolone Inj. Piperacillin/ Tazobactam (4.5 gm)

7-14 days or 6-8 hourly for 7-14 days

Inj. Linezolid (600 mg) Inj. Vancomycin (1 gm) I/V

12 hourly 7-14 days (if gram positive infection), or 12 hourly 7-14 days (if gram positive infection)

Inj. Ticoplzmin (400 mg) stat and (200 mg) Inj. Amphotericin-B if fungal infection

12 hourly for 7-14 days, or

Cap. Fluclonazole (50-100 mg/day) if fungal infection

Epiglottises
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (2 gm) Inj. Clarithromycin (900 mg)

24 hourly. Oral then: 8 hourly and

Tab. Co-amoxiclav (625 mg) Tab. Ciprofloxacin (500 gm)

Haemophilus influenzae (25%), followed by Haemophilus 8 hourly for 7-10 days 12 hourly. Oral then:
parainfluenzae, Streptococcus Pneumoniae, and group A
streptococci

Tab. Clindamycin (450 mg)


Haemophilus influenzae (25%), followed by Haemophilus
parainfluenzae, Streptococcus Pneumoniae, and group A
streptococci

6 hourly and

Tab. Ciprofloxacin (500 gm)

12 hourly

Lung Abscess
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Co-amoxiclav

Staphylococus Clindamycin, Vancomycin, Daptomycin, Linezolid


Metronidazole

Malignant Otitis Externa


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

3rd Generation Cepholosporins- Piperacillin hourly plus Topical


Inj. Clindamycin (900 mg) and (750 mg)
Treatment oral Stop down:

Pseudomonas

Tab. Ciprofloxacin (500 mg-750 mg) 8 hourly and 12 hourly

12 hourly for 4-6 weeks

Name: Ensure sueabs are taken prior to therapy. Switch to orals based on clinical assesment and microbiological results.

Assess for any bone and intracranial extension


All cases to be discumed with microbiology
Perichondritis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas 1st line

Mixed flora

Tab. Ciprofloxacin (500mg-750mg) for 12 hourly

2nd line:

Cap. Clindamycin (450mg) 6 hourly for 4-6 weeks

Pharyngitis/Tonsillitis
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug
GABHS (common) Mild: Mild:

Arcanobacterium hemolytic (7% or adolescents and adults with


Tab. Phenoxymethy1 penicillin (500 mg) Tab. Clarithromycin (500 mg)
pharyngitis)

Group C Streptococci (uncommon) 6 hourly 12 hourly

Group G Streptococci (uncommon)) Severe: Severe:

Neisseria Gonorrhoeae (uncommon) Inj. Benzy1 penicillin (1.2 gm) Inj. Clarithromycin (900 mg)

Coronibacterium diphtheria (rare) 6 hourly and 8 hourly. Oral then

Inj. Metronidazole (500 mg) Tab. Clindamycin (450 mg)

8 hourly. Oral then 8 hourly

Tab. Co-amoxiclav (625 mg)

8 hourly for 7-10 days.

Pneumonia
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Mostly unknown Inj. Meropenem (500 mg) Ceftazidime

Gram-ve Escherichia coli 8 hourly plus Cefepime

Inj.Amikacin (500 mg) I/V

12 hourly for 7 days

Quinsy (peritonsillar abscess)


Likely causative agent Antimicrobial of choice
Likely causative agent
Preferred drug
Alternative drug

Inj. Benzy1penicillin (1.2 gm) Inj. Clarithromycin (900 mg)

6 hourly and 8 hourly. Oral then

Inj. Metronidazole (500 mg) Tab. Clindamycin (450 mg)

Aerobic bacteria are Streptococcus group A (GAS), B-hemolytic


Streptococci group C and G, and Staphylococcus aureus Anaerobic
bacteria isolated form PTA aspirates is Fusobacterium necrophorum
8 hourly. Oral then 8 hourly

Tab. Co-amoxiclav (625 mg)

8 hourly for 7-10 days

Respiratory tract infection e.g. bronchitis Pneumonia


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Streptococcus Pneumoniae 3rd / 4th generation Cephalosporins Fluoroquinolones

Legionella pneumophetin Macrolide Macrolide

Mycoplasma

Haemophilus influenza

Staphylococcus aureus

Name: Nosocomial RTI is common in diabetic patient. Early and agresive treatment is required

Retropharyngeal Abscess Lateral pharyngeal Abscess


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Inj. Ceftriaxone (2 gm) Inj. Clarithromycin (900 mg)

24 hourly and 8 hourly and

Inj. Metronidazole (500 mg) Tab. Ciprofloxacin (500 gm)

4 hourly. Oral then: 12 hourly. Oral then:

Tab. Co-amoxiclav (625 mg) Tab. Clindamycin (450 mg)


8 hourly or according to C/S for 10-14 days 6 hourly and

Tab. Ciprofloxacin (500 gm)

12 hourly

Sore Throat
Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Please note that sore throat can be viral in nature. These do NOT
require antimicrobial therapy. Antibiotic treatment of adult
pharyngitis benefits only those patients with GABHS infection
Four clinical criteria (Centor criteria **) that predict infection with
GABHS include:(a) history of fever (b) tonsillar exudates (c)
absence of cough (d) tender anterior cervical lymphadenopathy
(lymphadenitis) Antibiotic therapy is recommended only for
patients who fulfill THREE or FOUR criteria. See below for
antibiotic recommendations for pharyngitis.Throat cultures are
not recommended for the routine primary evaluation of adults
with pharyngitis or for confirmation of negative results on rapid
antigen tests.

Upper or lower respiratory tract infection (Oncology)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pneumococcus Inj. Azithromycin (500 mg-1 gm)

Streptococcus 24 or 12 hourly for 3 days or

Staphylococcus

Tab. Azithromycin (500 mg)

3rd generation Cephalosporins or Quinolone derivatives


3rd generation Cephalosporins or Quinolone derivatives

orally 24 or 12 hourly for 3 days or

Tab. Co-amoxiclav (625 mg)

orally 8 hourly for 7 days

Ventilator associated pneumonia (Early VAP)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas Inj. Piperacillin/Tazobactam (4.5 gm) Inj. Meropenem (1 gm)

Acinatobacter 6-8 hourly for 7-14 days plus 8 hourly for 7-14 days or

Proteus Inj. Vancomycin (1 gm)

Klebsiella Inj. Amikacin (500 mg) 12 hourly or

Staphylococcus aureus 12 hourly for 7 days Inj. Colistin Sulphate (1-2 MU)

8 hourly for 7-14 days

Quinolone

for 7-14 days

Ventilator associated pneumonia (Late VAP)


Likely causative agent Antimicrobial of choice
Preferred drug
Alternative drug

Pseudomonas Inj. Meropenem (1 gm) Inj. Cefepime (1 gm)

Acinatobacter 8 hourly plus 8-12 hourly

Proteus

Klebsiella Inj. Amikacin (500 mg) Inj. Vancomycin (1 gm)

Staphylococcus aureus 12 hourly for 7 days 12 hourly

Inj. Colistin Sulphate (1-2 MU) Inj. Colistin Sulphate (1-2 MU)

8 hourly for 7-14 days 8 hourly for 7-14 days

You might also like